Cite

HARVARD Citation

    Feng, H. et al. (2021). High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer. Thoracic cancer. 12 (19), pp. 2564-2573. [Online]. 
  
Back to record